Cardiovascular disease (CVD) has emerged as a severe illness worldwide. Currently, the
top ten causes of death in the world include ischemic heart disease according to the Global …

In developed nations, health care spending is an increasingly important economic and
political issue. The discipline of cost-effectiveness (CE) analysis has developed over several …

The introduction of percutaneous transluminal coronary angioplasty (PTCA) revolutionized
the surgical treatment of coronary artery disease. However, despite increased surgical …

Background Our aim was to determine whether drug-eluting stents are good value for
money in long-term, everyday practice. Methods We did an 18-month cost-effectiveness …

Objectives: We sought to define what incremental risk of very late stent thrombosis (VLST) in
drug-eluting stents (DES) would outweigh the restenosis benefit. Background: Although …

Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization
for patients with three‐vessel or left main coronary artery disease (CAD). Background …

The problem of critical limb ischemia Peripheral arterial disease refers to the problem of
impaired arterial circulation to the lower extremities (specifically, an ankle-brachial index of …

Objectives: The aim of this study was to evaluate clinical and economic outcomes for
subjects receiving zotarolimus-eluting (ZES)(n= 323) versus sirolimus-eluting stents …

Objectives: This study was designed to evaluate long-term clinical and economic outcomes
for subjects receiving Endeavor drug-eluting versus Driver bare-metal stents (both Medtronic …

Background The aim of this propensity score-matched cohort study was to investigate the
prognostic impacts of drug-eluting stents (DES) and bare-metal stents (BMS) in patients …